HPV

  • Microarray patches likely to reduce the operational costs of immunization: A Monte Carlo simulation study

    Development of microneedle array patches (MAPs) for potential use in immunization is ongoing, but the cost of manufacturing is expected to be higher than that of existing needle-and-syringe vial systems. The potential benefits of MAPs in reaching previously unvaccinated populations have been touted, but affordability, especially in low- and middle-income countries, remains an open question.…

  • Women’s, reproductive, infant, and child health

    After years of improvement, the slowing pace of progress across many reproductive, maternal, newborn, and child health and nutrition outcomes has demonstrated that some populations are particularly challenging to reach with life-saving products, programs, and interventions. In general, the public health community has found it difficult to define and describe these hard-to-reach populations because there…

  • HPVsim: An agent-based model of HPV transmission and cervical disease

    In 2020, the WHO launched its first global strategy to accelerate the elimination of cervical cancer, outlining an ambitious set of targets for countries to achieve over the next decade. At the same time, new tools, technologies, and strategies are in the pipeline that may improve screening performance, expand the reach of prophylactic vaccines, and…